BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 1359137)

  • 1. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
    Smith S
    J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis associated with neuroleptic treatment. A case report.
    Kartaginer J; Ataya K; Mercado A; Abbasi A
    J Reprod Med; 1990 Feb; 35(2):198-202. PubMed ID: 1968102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
    Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
    Bunker MT; Marken PA; Schneiderhan ME; Ruehter VL
    J Child Adolesc Psychopharmacol; 1997; 7(1):65-9. PubMed ID: 9192542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
    Gioia P; Asnis G
    J Clin Psychiatry; 1988 Jan; 49(1):29-31. PubMed ID: 2891689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum prolactin level and bromoergocriptine therapy in galactorrhea and oligo- or amenorrhea].
    Baron J; Warenik-Szymankiewicz A; Chwalisz K
    Ginekol Pol; 1981 Jun; 52(6):517-20. PubMed ID: 7197249
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of bromocriptine on neuroleptic-induced amenorrhea, galactorrhea and impotence.
    Matsuoka I; Nakai T; Miyake M; Hirai M; Ikawa G
    Jpn J Psychiatry Neurol; 1986 Dec; 40(4):639-46. PubMed ID: 2885437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia with prolonged amenorrhea reversed with bromocriptine in a menopausal woman.
    Goldman M; Steinberger A; Ganti S
    Am J Obstet Gynecol; 1988 Jan; 158(1):117-8. PubMed ID: 3122579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
    Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
    N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of endocrinologic diagnosis in sterility patients. A clinical report of experiences].
    Melzer H; Uhlmann G
    Zentralbl Gynakol; 1985; 107(16):989-95. PubMed ID: 3931388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The physiopathological aspects of the normoprolactinemic amenorrhea-galactorrhea syndrome].
    Porias Cuéllas HL; Hernández Bueno JA; Villanueva C; Benavides S; Cortés-Gallegos V
    Ginecol Obstet Mex; 1987 Feb; 55():53-8. PubMed ID: 3154362
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
    Lombertie ER; Durelle G; Fuseau A
    Ann Med Psychol (Paris); 1995 Oct; 153(8):531-4. PubMed ID: 8561400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mania secondary to amantadine treatment of neuroleptic-induced hyperprolactinemia.
    Rego MD; Giller EL
    J Clin Psychiatry; 1989 Apr; 50(4):143-4. PubMed ID: 2564388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The assessment of the mental state of patients during simultaneous treatment with psychotropic drugs, antipsychotics included, and bromocriptine].
    Barszcz Z; Mucha S; Rabe-Jabłońska J
    Psychiatr Pol; 2008; 42(4):595-607. PubMed ID: 19189603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

  • 20. Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia.
    Frye PE; Pariser SF; Kim MH; O'Shaughnessy RW
    J Clin Psychiatry; 1982 Jun; 43(6):252-3. PubMed ID: 7200978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.